Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Smith & Nephew PLC (NYSE:SNN)

Delayed Data
As of Jan 12
 +0.39 / +1.12%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Smith & Nephew Plc is a global orthopedics company. It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management. The company operates in two divisions: Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices division offers, orthopaedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy and other ASD orthopaedic reconstruction includes hip implants, knee implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery. Its trauma and extremities consists of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; sports medicine joint repair, offers surgeons a broad array of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints; arthroscopy enabling technologies offer healthcare providers a variety of technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue; and other ASD includes gynaecological instrumentation and the remaining Clinical Therapies geographies which are in the process of being transferred to Bioventus. The Advanced Wound Devices division consists of traditional and single use negative pressure wound therapy, hydro surgery systems biologics and other bioactive technologies that provide unique approaches to debridement and dermal regeneration. Its products are used for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds. Smith & Nephew was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Contact Information

Smith & Nephew Plc
15 Adam Street
London London & South East WC2N 6LA
Investor Relations:



Other institutional5.41%
Mutual fund holders1.03%
Individual stakeholders--

Top Executives

Olivier Jean BohuonChief Executive Officer & Director
Matthew R. StoberPresident-Global Operations
Graham BakerChief Financial Officer & Director
Vasant PadmanabhanPresident-Research & Development
Arjun RajaratnamChief Compliance Officer